{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:45:45Z","timestamp":1794854745452,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41593-024-01620-8","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T06:19:29Z","timestamp":1713421169000},"page":"1116-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Identification of senescent, TREM2-expressing microglia in aging and Alzheimer\u2019s disease model mouse brain"],"prefix":"10.1038","volume":"27","author":[{"given":"Noa","family":"Rachmian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedi","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulysse","family":"Cherqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagay","family":"Akiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Deitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunya","family":"Edilbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-3429","authenticated-orcid":false,"given":"Tommaso","family":"Croese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer Meir","family":"Salame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9730-9001","authenticated-orcid":false,"given":"Javier Maria Peralta","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Cahalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-5482","authenticated-orcid":false,"given":"Valery","family":"Krizhanovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-7507","authenticated-orcid":false,"given":"Michal","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"1620_CR1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper, B. & Karran, E. The cellular phase of Alzheimer\u2019s disease. Cell 164, 603\u2013615 (2016).","journal-title":"Cell"},{"key":"1620_CR2","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray, T. & Rogers, J. Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2, a006346 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1620_CR3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal, T. A. et al. Microglial activation and tau propagate jointly across Braak stages. Nat. Med. 27, 1592\u20131599 (2021).","journal-title":"Nat. Med."},{"key":"1620_CR4","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1111\/bph.14546","volume":"176","author":"Z Moore","year":"2019","unstructured":"Moore, Z., Taylor, J. M. & Crack, P. J. The involvement of microglia in Alzheimer\u2019s disease: a new dog in the fight. Br. J. Pharmacol. 176, 3533\u20133543 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"1620_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1620_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1620_CR7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad8670","volume":"353","author":"O Matcovitch-Natan","year":"2016","unstructured":"Matcovitch-Natan, O. et al. Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016).","journal-title":"Science"},{"key":"1620_CR8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.it.2020.07.005","volume":"41","author":"G Castellani","year":"2020","unstructured":"Castellani, G. & Schwartz, M. Immunological features of non-neuronal brain cells: implications for Alzheimer\u2019s disease immunotherapy. Trends Immunol. 41, 794\u2013804 (2020).","journal-title":"Trends Immunol."},{"key":"1620_CR9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"1620_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2019.09.004","volume":"86","author":"L Karanfilian","year":"2020","unstructured":"Karanfilian, L., Tosto, M. G. & Malki, K. The role of TREM2 in Alzheimer\u2019s disease; evidence from transgenic mouse models. Neurobiol. Aging 86, 39\u201353 (2020).","journal-title":"Neurobiol. Aging"},{"key":"1620_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich, J. D., Ulland, T. K., Colonna, M. & Holtzman, D. M. Elucidating the role of TREM2 in Alzheimer\u2019s disease. Neuron 94, 237\u2013248 (2017).","journal-title":"Neuron"},{"key":"1620_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea, I. M. et al. Age and age-related diseases: role of inflammation triggers and cytokines. Front. Immunol. 9, 586 (2018).","journal-title":"Front. Immunol."},{"key":"1620_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","volume":"5","author":"E Jaul","year":"2017","unstructured":"Jaul, E. & Barron, J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front. Public Health 5, 335 (2017).","journal-title":"Front. Public Health"},{"key":"1620_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. & d\u2019Adda di Fagagna, F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1620_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch, K. et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89\u201393 (2014).","journal-title":"Science"},{"key":"1620_CR16","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.0402268101","volume":"101","author":"J Kipnis","year":"2004","unstructured":"Kipnis, J., Cohen, H., Cardon, M., Ziv, Y. & Schwartz, M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc. Natl Acad. Sci. USA 101, 8180\u20138185 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1620_CR17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nn1629","volume":"9","author":"Y Ziv","year":"2006","unstructured":"Ziv, Y. et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 9, 268\u2013275 (2006).","journal-title":"Nat. Neurosci."},{"key":"1620_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch, K. et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat. Commun. 6, 7967 (2015).","journal-title":"Nat. Commun."},{"key":"1620_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-2094-5-51","volume":"5","author":"B Giunta","year":"2008","unstructured":"Giunta, B. et al. Inflammaging as a prodrome to Alzheimer\u2019s disease. J. Neuroinflammation 5, 51 (2008).","journal-title":"J. Neuroinflammation"},{"key":"1620_CR20","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"1620_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.expneurol.2008.03.007","volume":"212","author":"H Rosenmann","year":"2008","unstructured":"Rosenmann, H. et al. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp. Neurol. 212, 71\u201384 (2008).","journal-title":"Exp. Neurol."},{"key":"1620_CR22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.194.9.1361","volume":"194","author":"RT Palframan","year":"2001","unstructured":"Palframan, R. T. et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194, 1361\u20131374 (2001).","journal-title":"J. Exp. Med."},{"key":"1620_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","volume":"2","author":"J Yang","year":"2014","unstructured":"Yang, J., Zhang, L., Yu, C., Yang, X.-F. & Wang, H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2, 1 (2014).","journal-title":"Biomark. Res."},{"key":"1620_CR24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbadis.2016.07.007","volume":"1862","author":"W Kamphuis","year":"2016","unstructured":"Kamphuis, W., Kooijman, L., Schetters, S., Orre, M. & Hol, E. M. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer\u2019s disease. Biochim. Biophys. Acta 1862, 1847\u20131860 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"1620_CR25","doi-asserted-by":"crossref","first-page":"e0293301","DOI":"10.1371\/journal.pone.0293301","volume":"18","author":"JA Carroll","year":"2023","unstructured":"Carroll, J. A., Striebel, J. F., Baune, C., Chesebro, B. & Race, B. CD11c is not required by microglia to convey neuroprotection after prion infection. PLoS ONE 18, e0293301 (2023).","journal-title":"PLoS ONE"},{"key":"1620_CR26","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman, S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896\u20131905 (2013).","journal-title":"Nat. Neurosci."},{"key":"1620_CR27","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","volume":"9","author":"SE Haynes","year":"2006","unstructured":"Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512\u20131519 (2006).","journal-title":"Nat. Neurosci."},{"key":"1620_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/glia.23097","volume":"65","author":"A Mildner","year":"2017","unstructured":"Mildner, A., Huang, H., Radke, J., Stenzel, W. & Priller, J. P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia 65, 375\u2013387 (2017).","journal-title":"Glia"},{"key":"1620_CR29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1567205013666151116125714","volume":"13","author":"JJ Merino","year":"2016","unstructured":"Merino, J. J., Mu\u00f1et\u00f3n-G\u00f3mez, V., Alv\u00e1rez, M.-I. & Toledano-D\u00edaz, A. Effects of CX3CR1 and Fractalkine chemokines in amyloid beta clearance and p-tau accumulation in Alzheimer\u02bcs disease (AD) rodent models: is Fractalkine a systemic biomarker for AD? Curr. Alzheimer Res. 13, 403\u2013412 (2016).","journal-title":"Curr. Alzheimer Res."},{"key":"1620_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","volume":"13","author":"SW Lowe","year":"2003","unstructured":"Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a\u2013Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77\u201383 (2003).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1620_CR31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593\u2013602 (1997).","journal-title":"Cell"},{"key":"1620_CR32","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s00018-014-1691-3","volume":"71","author":"DG Burton","year":"2014","unstructured":"Burton, D. G. & Krizhanovsky, V. Physiological and pathological consequences of cellular senescence. Cell. Mol. Life Sci. 71, 4373\u20134386 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"1620_CR33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/25870","volume":"395","author":"I Palmero","year":"1998","unstructured":"Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumour suppressor p53 to Ras. Nature 395, 125\u2013126 (1998).","journal-title":"Nature"},{"key":"1620_CR34","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/emboj.2011.69","volume":"30","author":"A Freund","year":"2011","unstructured":"Freund, A., Patil, C. K. & Campisi, J. p38MAPK is a novel DNA damage response\u2010independent regulator of the senescence\u2010associated secretory phenotype. EMBO J. 30, 1536\u20131548 (2011).","journal-title":"EMBO J."},{"key":"1620_CR35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638\u2013642 (2006).","journal-title":"Nature"},{"key":"1620_CR36","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1093\/emboj\/cdg417","volume":"22","author":"CM Beaus\u00e9jour","year":"2003","unstructured":"Beaus\u00e9jour, C. M. et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 4212\u20134222 (2003).","journal-title":"EMBO J."},{"key":"1620_CR37","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1093\/emboj\/16.19.6018","volume":"16","author":"H Vaziri","year":"1997","unstructured":"Vaziri, H. et al. ATM\u2010dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post\u2010translational activation of p53 protein involving poly (ADP\u2010ribose) polymerase. EMBO J. 16, 6018\u20136033 (1997).","journal-title":"EMBO J."},{"key":"1620_CR38","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.820127","volume":"16","author":"D Mercurio","year":"2022","unstructured":"Mercurio, D. et al. Protein expression of the microglial marker Tmem119 decreases in association with morphological changes and location in a mouse model of traumatic brain injury. Front. Cell. Neurosci. 16, 820127 (2022).","journal-title":"Front. Cell. Neurosci."},{"key":"1620_CR39","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1212\/NXI.0000000000000512","volume":"6","author":"M Gissl\u00e9n","year":"2018","unstructured":"Gissl\u00e9n, M. et al. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol. Neuroimmunol. Neuroinflamm. 6, e512 (2018).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1620_CR40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","volume":"129","author":"C Cantoni","year":"2015","unstructured":"Cantoni, C. et al. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 129, 429\u2013447 (2015).","journal-title":"Acta Neuropathol."},{"key":"1620_CR41","first-page":"2125\u20132139","volume":"12","author":"C Jin","year":"2021","unstructured":"Jin, C. et al. A unique type of highly-activated microglia evoking brain inflammation via Mif\/Cd74 signaling axis in aged mice. Aging Dis. 12, 2125\u20132139 (2021).","journal-title":"Aging Dis."},{"key":"1620_CR42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581 (2017).","journal-title":"Immunity"},{"key":"1620_CR43","first-page":"31\u201341","volume":"150","author":"P Gasque","year":"1997","unstructured":"Gasque, P., Singhrao, S. K., Neal, J. W., G\u00f6tze, O. & Morgan, B. P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150, 31\u201341 (1997).","journal-title":"Am. J. Pathol."},{"key":"1620_CR44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso, A. et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain 139, 891\u2013907 (2016).","journal-title":"Brain"},{"key":"1620_CR45","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/glia.22501","volume":"61","author":"J Kopatz","year":"2013","unstructured":"Kopatz, J. et al. Siglec\u2010h on activated microglia for recognition and engulfment of glioma cells. Glia 61, 1122\u20131133 (2013).","journal-title":"Glia"},{"key":"1620_CR46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fnins.2019.00410","volume":"13","author":"M Jakovljevic","year":"2019","unstructured":"Jakovljevic, M. et al. Induction of NTPDase1\/CD39 by reactive microglia and macrophages is associated with the functional state during EAE. Front. Neurosci. 13, 410 (2019).","journal-title":"Front. Neurosci."},{"key":"1620_CR47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s43587-021-00149-w","volume":"2","author":"R Dvir-Szternfeld","year":"2022","unstructured":"Dvir-Szternfeld, R. et al. Alzheimer\u2019s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis. Nat. Aging 2, 60\u201373 (2022).","journal-title":"Nat. Aging"},{"key":"1620_CR48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"1620_CR49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","volume":"41","author":"N Bancaro","year":"2023","unstructured":"Bancaro, N. et al. Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer. Cancer Cell 41, 602\u2013619.e11 (2023).","journal-title":"Cancer Cell"},{"key":"1620_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"1620_CR51","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).","journal-title":"Nat. Commun."},{"key":"1620_CR52","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan, S. et al. White matter aging drives microglial diversity. Neuron 109, 1100\u20131117 (2021).","journal-title":"Neuron"},{"key":"1620_CR53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI95149","volume":"128","author":"Y Ovadya","year":"2018","unstructured":"Ovadya, Y. & Krizhanovsky, V. Strategies targeting cellular senescence. J. Clin. Invest. 128, 1247\u20131254 (2018).","journal-title":"J. Clin. Invest."},{"key":"1620_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef, R. et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat. Commun. 7, 11190 (2016).","journal-title":"Nat. Commun."},{"key":"1620_CR55","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531\u20132537 (2013).","journal-title":"Nat. Protoc."},{"key":"1620_CR56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/glia.23782","volume":"68","author":"WJ Streit","year":"2020","unstructured":"Streit, W. J., Khoshbouei, H. & Bechmann, I. Dystrophic microglia in late\u2010onset Alzheimer\u2019s disease. Glia 68, 845\u2013854 (2020).","journal-title":"Glia"},{"key":"1620_CR57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit, W. J., Braak, H., Xue, Q.-S. & Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol. 118, 475\u2013485 (2009).","journal-title":"Acta Neuropathol."},{"key":"1620_CR58","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018).","journal-title":"Nature"},{"key":"1620_CR59","doi-asserted-by":"crossref","first-page":"e13450","DOI":"10.1111\/acel.13450","volume":"20","author":"N Talma","year":"2021","unstructured":"Talma, N., Gerrits, E., Wang, B., Eggen, B. J. & Demaria, M. Identification of distinct and age\u2010dependent p16High microglia subtypes. Aging Cell 20, e13450 (2021).","journal-title":"Aging Cell"},{"key":"1620_CR60","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow, K. et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol. Med. 12, e11227 (2020).","journal-title":"EMBO Mol. Med."},{"key":"1620_CR61","doi-asserted-by":"crossref","first-page":"e20220654","DOI":"10.1084\/jem.20220654","volume":"220","author":"N Jain","year":"2023","unstructured":"Jain, N., Lewis, C. A., Ulrich, J. D. & Holtzman, D. M. Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. J. Exp. Med. 220, e20220654 (2023).","journal-title":"J. Exp. Med."},{"key":"1620_CR62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cell.2022.12.010","volume":"186","author":"WE Allen","year":"2023","unstructured":"Allen, W. E., Blosser, T. R., Sullivan, Z. A., Dulac, C. & Zhuang, X. Molecular and spatial signatures of mouse brain aging at single-cell resolution. Cell 186, 194\u2013208.e18 (2023).","journal-title":"Cell"},{"key":"1620_CR63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat. Neurosci. 22, 719\u2013728 (2019).","journal-title":"Nat. Neurosci."},{"key":"1620_CR64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-021-00458-z","volume":"16","author":"H Ben-Yehuda","year":"2021","unstructured":"Ben-Yehuda, H. et al. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy. Mol. Neurodegener. 16, 39 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1620_CR65","doi-asserted-by":"crossref","unstructured":"Zhao, N. & Bu, G. A TREM2 antibody energizes microglia. Nat. Neurosci. 26, 366\u2013369 (2023).","DOI":"10.1038\/s41593-023-01265-z"},{"key":"1620_CR66","doi-asserted-by":"crossref","unstructured":"Rachmian, N. & Krizhanovsky, V. Senescent cells in the brain and where to find them. FEBS J. 290, 1256\u20131266 (2022).","DOI":"10.1111\/febs.16649"},{"key":"1620_CR67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2020.09.015","volume":"91","author":"Z Xing","year":"2021","unstructured":"Xing, Z. et al. Influenza vaccine combined with moderate-dose PD1 blockade reduces amyloid-\u03b2 accumulation and improves cognition in APP\/PS1 mice. Brain Behav. Immun. 91, 128\u2013141 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1620_CR68","doi-asserted-by":"crossref","first-page":"769229","DOI":"10.3389\/fcell.2021.769229","volume":"9","author":"Y Zou","year":"2021","unstructured":"Zou, Y. et al. Programmed cell death protein 1 blockade reduces glycogen synthase kinase 3\u03b2 activity and tau hyperphosphorylation in Alzheimer\u2019s disease mouse models. Front. Cell Dev. Biol. 9, 769229 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1620_CR69","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig, N. et al. PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat. Commun. 10, 465 (2019).","journal-title":"Nat. Commun."},{"key":"1620_CR70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 22, 135\u2013137 (2016).","journal-title":"Nat. Med."},{"key":"1620_CR71","doi-asserted-by":"publisher","unstructured":"Majewska, J. et al. p16-dependent upregulation of PD-L1 impairs immunosurveillance of senescent cells. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.01.30.524522 (2023).","DOI":"10.1101\/2023.01.30.524522"},{"key":"1620_CR72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","volume":"611","author":"T-W Wang","year":"2022","unstructured":"Wang, T.-W. et al. Blocking PD-L1\u2013PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358\u2013364 (2022).","journal-title":"Nature"},{"key":"1620_CR73","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663 (2017).","journal-title":"Cell"},{"key":"1620_CR74","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41596-018-0016-7","volume":"13","author":"G Han","year":"2018","unstructured":"Han, G., Spitzer, M. H., Bendall, S. C., Fantl, W. J. & Nolan, G. P. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry. Nat. Protoc. 13, 2121\u20132148 (2018).","journal-title":"Nat. Protoc."},{"key":"1620_CR75","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins, R. A. & Besheer, J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory\u2019. Nat. Protoc. 1, 1306\u20131311 (2006).","journal-title":"Nat. Protoc."},{"key":"1620_CR76","unstructured":"Bj\u00f6rklund, \u00c5. Single RNA-seq data analysis with R: quality control. Github https:\/\/nbisweden.github.io\/excelerate-scRNAseq\/session-qc\/Quality_control.html (2019)."},{"key":"1620_CR77","unstructured":"Rachmian, N. & Deitch, D. Trem2_senescent_microglia. Github https:\/\/github.com\/NoaRachmian\/Trem2_senescent_microglia (2024)."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-024-01620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-024-01620-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-024-01620-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:04:45Z","timestamp":1717700685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-024-01620-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1038\/s41593-024-01620-8","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,18]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.K. is a co-inventor of patents on senolytics and senolytic approaches and is a consultant for Sentaur Bio. None of these interests influenced the data presented in this manuscript. M.S. is a scientific co-founder of ImmunoBrain Checkpoint, which develops anti-PD-L1 to treat Alzheimer\u02bcs disease. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}